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Although it is well established that both follicular assembly and the initiation of follicle growth in the mammalian ovary occur
independently of pituitary hormone support, the factors controlling these processes remain poorly understood. We now report that
neurotrophins (NTs) signaling via TrkB receptors are required for the growth of newly formed follicles. Both neurotrophin-4/5 (NT-4) and
brain-derived neurotrophic factor (BDNF), the preferred TrkB ligands, are expressed in the infantile mouse ovary. Initially, they are present in
oocytes, but this site of expression switches to granulosa cells after the newly assembled primordial follicles develop into growing primary
follicles. Full-length kinase domain-containing TrkB receptors are expressed at low and seemingly unchanging levels in the oocytes and
granulosa cells of both primordial and growing follicles. In contrast, a truncated TrkB isoform lacking the intracellular domain of the receptor
is selectively expressed in oocytes, where it is targeted to the cell membrane as primary follicles initiate growth. Using gene-targeted mice
lacking all TrkB isoforms, we show that the ovaries of these mice or those lacking both NT-4 and BDNF suffer a stage-selective deficiency in
early follicular development that compromises the ability of follicles to grow beyond the primary stage. Proliferation of granulosa cells—
required for this transition—and expression of FSH receptors (FSHR), which reflects the degree of biochemical differentiation of growing
follicles, are reduced in trkB-null mice. Ovaries from these animals grafted under the kidney capsule of wild-type mice fail to sustain
follicular growth and show a striking loss of follicular organization, preceded by massive oocyte death. These results indicate that TrkB
receptors are required for the early growth of ovarian follicles and that they exert this function by primarily supporting oocyte development as
well as providing granulosa cells with a proliferative signal that requires oocyte-somatic cell bidirectional communication. The predominance
of truncated TrkB receptors in oocytes and their developmental pattern of subcellular expression suggest that a significant number of NT-4/
BDNF actions in the developing mammalian ovary are mediated by these receptors.
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sity Medical Center, Washington, DC 20057, USA.1994). Although it was once believed that NTs were
required only within the nervous system, the presence of
their high-affinity Trk receptors in several nonneuronal
tissues has led to the conclusion that NTs may also be
required for the development and function of organs as
diverse as those comprising the cardiovascular, immune,
endocrine, and reproductive systems (reviewed in Tessar-
ollo, 1998). The critical importance of two NTs, nerve
growth factor (NGF) and neurotrophin-3 (NT-3), and their
respective TrkA and TrkC receptors in the morphogenesis of
such organs was recently demonstrated by the severe defects
in thymus, heart, and ovarian development detected in mice
lacking the receptors TrkA (Garcı´a-Sua´rez et al., 2000) or
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al., 2001) and NT-3 (Donovan et al., 1996). NTs also appear
to play a role in vascular development since the complete
ablation of the pan NT receptor p75NTR, which recognizes
all neurotrophins with similar affinity (Chao and Hemp-
stead, 1995), results in defects of blood vessel formation
(von Schack et al., 2001).
Much less is known about the functions that neuro-
trophin-4 (NT-4) and brain-derived neurotrophic factor
(BDNF), and their TrkB receptors may have outside the
nervous system. The recent finding that mice lacking BDNF
suffer from specific defects of the cardiac vasculature
(Donovan et al., 2000) provided bona fide evidence for
the existence of such nonneural functions. Whether the NT-
4/BDNF ligand or TrkB receptor complex is also required
for normal morphogenesis of other organs has not been
established. Within the endocrine system, the developing
ovary is a particularly suitable candidate for such TrkB-
mediated actions because it expresses both NT-4 and BDNF,
as well as TrkB receptors, at a developmental stage during
which its functional units, the follicles, become first assem-
bled and begin to grow towards acquiring ovulatory com-
petence (Anderson et al., 2002; Dissen et al., 1995).
Female reproductive capacity requires the ability of the
ovary to yield a mature oocyte at ovulation. Oocytes grow
surrounded by somatic cells of both epithelial (granulosa)
and mesenchymal (theca) origin that together form a func-
tional unit known as the follicle (Matzuk et al., 2002). In
rodents, assembly of somatic and germ cells into follicular
structures is completed within the first week of postnatal life
(Hirshfield, 1991; Malamed et al., 1992). Both follicular
formation and the initiation of follicle growth occur inde-
pendently of pituitary gonadotropin hormone support (Dier-
ich et al., 1998; Kumar et al., 1997; Zhang et al., 2001).
Instead, these events are regulated by intraovarian factors,
some of which have been identified (Dissen et al., 2001;
Dong et al., 1996; Huang et al., 1993) (reviewed in Matzuk
et al., 2002). Because the mRNAs encoding BDNF and NT-
4 and their TrkB receptor are expressed in neonatal rat
ovaries (Dissen et al., 1995), it has been suggested that TrkB
signaling may be involved in regulating either follicular
assembly or the initiation of follicular growth (Dissen et al.,
1995). Alternative splicing of the TrkB pre-mRNA gener-
ates both a full-length receptor that uses an intracellular
tyrosine kinase domain for signaling, and truncated isoforms
containing the identical extracellular and transmembrane
domain as the full-length receptor, but lacking the intracel-
lular kinase domain (Klein et al., 1990; Middlemas et al.,
1991). Though lacking canonical signaling motifs, these
truncated forms are also able to initiate intracellular signal-
ing (Baxter et al., 1997), suggesting that if they are present
in the developing ovary, they may contribute to regulating
specific ovarian functions. Mice lacking only the full-length
TrkB receptor cannot be used to define the role of trkB in
postnatal follicular growth because most of the mutant
animals die at birth (Klein et al., 1993). A less severephenotype is, however, observed in mice lacking both
full-length and truncated receptor isoforms, as these animals
can survive for up to 3 weeks after birth (Rohrer et al.,
1999).
In the present study, we report the gene targeting proce-
dure employed to generate these mice and demonstrate that
in the absence of both full-length and truncated TrkB
receptors, ovarian follicular growth is arrested at an early
stage of development. This deficiency is accompanied by
reduced granulosa cell proliferation. We further demonstrate
that the ovaries from trkB-null mice transplanted under the
kidney capsule of wild-type recipient animals, and left in
this site for 2 weeks to assess the ability of follicles to grow
beyond the preantral stage, are unable to support oocyte
survival and follicular growth, resulting in widespread
degradation of follicular organization. While most TrkB
receptors in the neonatal mouse ovary are truncated and
predominantly expressed in oocytes, BDNF and NT-4 are
produced by follicular granulosa cells. This distribution
suggest that the arrest in follicular growth observed in
trkB-null mice is due to impairment of a TrkB-mediated
signaling pathway that primarily affects oocyte function,
resulting in loss of a germ cell-somatic cell communication
process that supports proliferation of follicular somatic cells
and hence is required for follicle growth. Because most
TrkB receptors expressed in oocytes are truncated, it appears
likely that these receptors play a significant role in mediat-
ing the supporting actions of NT-4/BDNF on ovarian
follicular development.Materials and methods
Generation of trkB-null mutant mice
The 10 kb of XbaI–BamHI trkB genomic fragment
(thick line in Fig. 1A) covering the first coding exon (exon
S) was described previously (Xu et al., 2000) and used to
construct the trkB targeting vector (Fig. 1A). Exon S covers
a 346-bp 5Vuntranslated region (open box) and a 211-bp
coding region including 31 codons for the signal peptide
(black filled box). A ClaI site located at the 19th bp of
exon S and a KpnI site located 112 bp downstream of exon
S were two critical restriction sites for construction of the
targeting vector. To construct the targeting vector, the
ClaI–KpnI fragment was replaced with a PGKneo expres-
sion unit (Fig. 1A). The targeting vector contains 7 kb of
XbaI–ClaI upstream homologous arm and 2.5 kb of KpnI–
BamHI downstream homologous arm. A negative selection
gene, PGKtk, was inserted downstream of the 2.5-kb
homologous arm. Using this construct, trkB mutants were
generated following standard procedures. A trkB cDNA
fragment (nt1386–2054 in mouse TrkB mRNA) was used
as the probe for Northern hybridization. Additional details
concerning the postnatal phenotype of these mutant mice
have been previously described (Rohrer et al., 1999).
Fig. 1. Targeting disruption of the trkB gene. (A) Schematic diagrams of the trkB gene, the targeting construct, and the targeted trkB locus. The probes used for
screening and the expected Southern blot fragments are indicated. The homology arms are represented in thick lines. B = BamHI; H = HindIII. (B) Southern
blot analyses of a representative tail DNA sample. DNAwas digested with BamHI or HindIII and blotted with probe A or probe B. Using probe A, 10.5 and 8.5
kb bands are generated by digestion of the wild-type trkB and the targeted trkB alleles, respectively. Probe B detects 2.4 and 6.0 kb of bands for the wild-type
trkB and the targeted trkB alleles, respectively. (C) Northern blot analysis of trkB mRNAs. Half microgram of brain mRNA was loaded onto each lane. An
asterisk indicates the presence of an aberrant RNA in the mutant (/) lane. (D) Western blot analysis of the TrkB protein. Protein extracts were prepared from
the brains of wild-type, heterozygous, and homozygous mice. Fifty micrograms of protein was loaded onto each lane. Alpha tubulin was used as the loading
control. TrkB = full-length TrkB receptor; TrkB-T = truncated TrkB receptor.
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The affinity purified TrkB antibodies (RTB) for Western
blot were raised against the TrkB extracellular domain
(Huang et al., 1999). They were used at a 1:200 dilution.
Nonspecific binding to the membrane containing the elec-
trophoresed proteins was blocked with 5% dry milk in
TBST buffer (10 mM Tris, pH 7.5, 150 mM NaCl, 0.05%
Tween).
Immunohistochemistry
Immunoreactive TrkB receptor forms and BDNF were
detected in 14-Am cryostat sections from ovaries im-mersed in Zamboni’s fixative either overnight (Dissen
et al., 1995) or for 2 h at 4jC. The potassium phosphate
buffers used for the immunohistofluorescence procedures
outlined below were those described earlier (Jung et al.,
1997). The full-length TrkB protein was detected with a
rabbit antiserum (TrkB-in, 1:500, kindly provided by Dr.
David Kaplan, Montreal Neurological Institute, McGill
University, Montreal, Canada), directed against amino
acids 482–501 in the cytoplasmic domain of TrkB (Fryer
et al., 1996). Truncated TrkB-T1 receptors were identified
with rabbit polyclonal antibodies (SC-119, 1:500, Santa
Cruz Biotechnology, Santa Cruz, CA). BDNF-containing
cells were identified using rabbit polyclonal antibodies
against human BDNF (AB1779SP, 1:2000, Chemicon
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these primary antibodies, the sections were treated with
avidin-blocking solution, as described (Jung et al., 1997).
To verify the localization of truncated TrkB-T1 receptors
to the cell membrane of oocytes, a double immunolabel-
ing experiment was performed using the TrkB-T1 anti-
bodies described above and a rat monoclonal antibody
(Mab KMC8, 5 Ag/ml, BD Pharmigen, San Diego, CA)
against mouse CD9, a member of the tetraspanin family
of membrane proteins that is selectively expressed in the
plasma membrane of oocytes (Zhu et al., 2002). After an
overnight incubation at 4jC with the primary antibodies,
all TrkB immunoreactions were developed by incubating
the sections for 1 h at room temperature with biotiny-
lated goat antirabbit gamma globulin (1:250, Vector
Laboratories, Inc., Burlingame, CA) followed by 1 h at
room temperature with fluorescein (FITC) streptavidin
(1:400, Jackson ImmunoResearch, West Grove, PA).
CD9 immunoreactions were developed with Texas Red-
labeled goat antirat gamma globulin 1 h at room tem-
perature (1:250, Jackson ImmunoResearch), added to the
sections simultaneously with the biotinylated antibodies
against TrkB-T1. In the case of BDNF, the immuno-
reactions were developed using the biotinylated tyramine
enhancement method, as previously described (Jung et
al., 1997). In brief, after an overnight incubation with the
primary antibodies, the sections were incubated with
biotinylated goat antirabbit gamma globulin (1:2000, 1
h at room temperature), followed by 1 h incubation in
avidin–biotin complex (ABC, Elite Vectastain, Vector
Laboratories). After extensive rinsing, the sections were
incubated for 20 min at room temperature with biotiny-
lated tyramine (BT, 5 Al/ml, PerkinElmer Life Sciences,
Inc., Boston, MA) containing 0.001% hydrogen peroxide.
Thereafter, the sections were washed again several times
and incubated for 2 h at 37jC with FITC-streptavidin at
a 1:1000 dilution. Cell nuclei were stained with the vital
dye Hoechst (Molecular Probes, Eugene, OR) as reported
(Dissen et al., 2001). To identify NT-4 immunoreactive
cells, the ovaries were immersed in Bouin’s fixative for 4
h, embedded in paraffin, and sectioned at 5 Am. The
sections were then subjected to an antigen retrieval
procedure (Dissen et al., 2001), followed by incubation
with rabbit polyclonal antibodies against human NT-4
(SC 545, 1:250, Santa Cruz Biotechnology, Santa Cruz,
CA). NT-4 immunoreactions were developed as described
for light microscopy immunohistochemistry (Anesetti et
al., 2001). Several controls were used, including sections
from ovaries of trkB / mice in the case of the TrkB
immunoreactions, sections from ovaries of BDNF /
animals (Bennett et al., 1999) in the case of BDNF
staining, and sections incubated with antibodies pread-
sorbed with the peptide used to raise the antibodies in
the case of NT-4 (SC545P, 10 Ag peptide/Ag antibody,
Santa Cruz Biotechnology, 2 h at room temperature).
Confocal images were acquired as reported (Dissen et al.,2001) using a Leica TCS SP confocal system (Leica
Microsystems, Heidelberg, Germany) equipped with a
40 Plan Apochromat objective (1.25 numerical aper-
ture). Hoescht and FITC were imaged using the 361-nm
line of a UV laser and the 488-nm line of an Argon laser
for excitation. The two fluorophores were imaged se-
quentially to exclude the contribution of Hoescht into the
FITC channel and processed as described (Dissen et al.,
2001).
Morphometric analysis
The ovaries of 7-day-old trkB +/+, trkB /, and trkB
+/ mice were fixed in Kahle’s fixative, embedded in
paraffin, serially sectioned at 6 Am, and stained with
Weigert’s iron hematoxylin and counterstained with picric
acid-methyl blue, as reported (Dissen et al., 2001). Every
third section was imaged on a Zeiss Axioplan (Carl Zeiss,
Jenna, Germany), using a CoolSnap camera (Roper Scien-
tific, Stillwater, MN). Follicles were counted using the
manual count feature of MetaMorph (Universal Imaging
Co., West Chester, PA). Only follicles in which the nucleus
of the oocyte was visible were counted, and the total
number of follicles per ovary was determined as reported
(Dissen et al., 2001). All counts were performed without
previous knowledge of the animal’s genotype.
Ovarian transplantation
Eight- to 10-week-old intact adult female mice C57BL/
6J were used as recipients for ovarian transplantation. The
recipient mice were anesthetized with a subcutaneous
injection of a combination of ketamine hydrochloride (30
mg/kg; Fort Dodge Animal Health, Fort Dodge, IA),
xylazine (2 mg/kg; Phoenix Scientific Inc., St. Joseph,
MO), and acepromazine maleate (1 mg/kg; Burns Veteri-
nary Supply, Rockville Centre, NY). The kidneys were
sequentially exteriorized through dorsolateral incisions, and
one donor ovary was inserted under the renal capsule
of each kidney with the help of fine watchmakers forceps.
The donor ovaries, derived from 4- to 5-day-old trkB +/+,
trkB +/, and trkB / animals were dissected out,
cleaned of adherent tissue, and kept in DMEM (Sigma-
Aldrich, St. Louis, MO) until transplantation. After receiv-
ing the ovarian grafts, the recipient mice were ovariecto-
mized. The incision was closed with 4-0 Biosyn
monofilament synthetic absorbable sutures (Tyco Health-
care Group LP., Norwalk, CT) and 9 mm Autoclips (Becton
Dickinson and Company, Sparks, MD). After surgery, each
mouse received subcutaneous injections of the antibiotic
Enrofloxacin (85 mg kg1 day1; Bayer Corp., Shawnee
Mission, KA) for 3 days and the analgesic Ketoprofen (2.5
mg kg1 day1; Fort Dodge Animal Health) for 2 days.
Two weeks after transplantation, the ovaries were collected
and processed for morphologic examination as described
above.
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The ovaries from 7-day-old trkB +/+ and trkB /
mice were fixed in Carnoy’s fixative, embedded in paraf-
fin, sectioned at 4 Am, and subjected to immunohisto-
chemistry for PCNA, as reported (Dissen et al., 2001),
using a monoclonal antibody to PCNA (Mab PC-10,
1:1000; Santa Cruz Biotechnology) and developing the
immunoreaction with a diaminobenzidine/H2O2/nickel
chloride solution, followed by counterstaining with Gill’s
hematoxylin (1:10 dilution). As an independent measure of
cell proliferative activity, the ovaries from 7 day-old trkB
+/+ and trkB / mice were explanted into an organ
culture system (Mayerhofer et al., 1997) and incubated
with bromodeoxy-uridine (BrdU, 100 AM; Roche Diag-
nostics Co., Indianapolis, IN) for 24 h at 37jC in an
atmosphere of 60% oxygen, 35% nitrogen, and 5% CO2,
as reported (Dissen et al., 2001). Thereafter, the ovaries
were fixed and sectioned as above before BrdU immuno-
histochemistry, which was performed using a monoclonal
antibody to BrdU (Mab B-2531, 1:1000; Sigma-Aldrich).
Every fifth section was imaged with a Sony DKC-5000
digital camera (Sony, Co., Tokyo, Japan) attached to a
Nikon Eclipse E600 microscope using a Plan 40 NA
0.65 objective (Nikon Inc., Melville, NY). Positive cells
were counted using the manual feature of MetaMorph. In
the case of PCNA staining, only positive granulosa cells
were counted; in the case of BrdU staining, the sections
were counterstained with Nuclear Fast Red (Vector Labo-
ratories, undiluted for 10 min at room temperature fol-
lowed by a 10-s wash in water containing 0.5% acetic
acid) for accurate visualization of nonproliferating, BrdU-
negative cells.
Assessment of apoptosis
Apoptotic ovarian cells were detected in 14 Am
cryostat sections using the in situ cell death detection
kit coupled with fluorescein detection (Roche Diagnos-
tics Co.), following the manufacturer’s instructions.
Ovaries from 7-day-old trkB +/+, trkB / mice, and
adult ovaries from a 34-day-old mouse were immersion
fixed for 24 h at 4jC in Zamboni’s fixative, rinsed in
PBS (24 h at 4jC), and then cryoprotected in 20%
sucrose-PBS overnight at 4jC before embedding them
in OCT compound (Miles Inc., Elkhart, IN), and dry
ice freezing.
Relative quantitative PCR and RealTime PCR
To determine if the absence of TrkB receptors alters the
expression of receptor-ligand systems currently known to
be required for early follicular growth, the mRNAs encod-
ing these proteins were measured using quantitative PCR
procedures. Once follicles acquire two or more layers of
granulosa cells, these cells begin to express FSH receptors(FSHR). To determine if this differentiation process is
delayed in trkB / mice, we also measured FSHR
mRNA by quantitative PCR. The relative quantitative
PCR procedure of Ambion (Austin, TX) was used to
detect the mRNAs encoding the receptors c-kit and bone
morphogenetic protein receptor type II (BMPRII). C-kit,
the c-kit ligand (KL) receptor, is predominantly expressed
in oocytes (Manova et al., 1990), and BMPRII, a putative
GDF-9 receptor (Vitt et al., 2002) (see below), is present
in granulosa cells (Shimasaki et al., 1999). Before carrying
out the amplification procedure, the optimal gene-specific
primer concentrations, linear range of the PCR reaction,
and optimal primer concentration for the amplification of
18S ribosomal RNA used as an internal standard were
determined. The primers used for c-kit receptor mRNA
amplification (GenBank accession number NM 021099)
were a 5V forward primer (5V-GTGCCAACCAAGACAGA-
CAA-3V) corresponding to NT 2216–2235 and a 3V reverse
primer (5V-GGCTGCCAAATCTCTGTGAA-3V) comple-
mentary to nucleotides (NT) 2407–2426 in the c-kit
mRNA sequence (Qiu et al., 1988). BMPRII mRNA
(GeneBank accession number NM_007561) was detected
with a 5V forward primer 5V-TTTGGTAGATAGGAGG-
GAACG-3V and a reverse primer 5V-ATTTGCCATCTT-
GTGTTGACT-3V corresponding to NTs 2674–2690 and
2888–3009, respectively, in BMPRII mRNA (Bepu et al.,
1997). The PCR reactions were carried out in a 25-
Al volume containing 0.5 Al of reverse transcription
reaction, 10 pmol (c-kit) or 15 pmol (BMPRII) of gene-
specific primers, and 25 pmol of 18S ribosomal RNA
primers at a primer/competimer ratio of 1:1. The PCR
amplification protocol consisted of 30 cycles of denaturing
at 94jC (30 s), annealing at 55jC (30 s), and extension at
72jC (1 min). Equal volumes of the PCR reactions were
electrophoresed on 2% agarose gels stained with ethidium
bromide, the gels were imaged in a Gel Doc 2000 (Bio-
Rad Laboratories, Hercules, CA), and the images were
quantitated using the image analysis Quantity One soft-
ware (Bio-Rad Laboratories).
The mRNAs encoding KL (Huang et al., 1993) and the
putative BMPRII ligand GDF-9 (Vitt et al., 2002) were
detected by RealTime PCR using a procedure previously
described (Romero et al., 2002). GDF-9 mRNA is
expressed exclusively in oocytes (Dong et al., 1996;
McGrath et al., 1995) and is recognized by BMPRII (Vitt
et al., 2002). To detect it, we used a 5V forward primer (5V-
CGATGGTGGACCTGCTGTTT-3V) corresponding to NT
435–454 and a 3V reverse primer (5V-GGAGGAAGAGG-
CAGAGTT GTT C-3V) complementary to NT 515–535 in
mouse GDF-9 mRNA (GenBank accession number
NM_008110). The internal fluorescent oligodeoxynucleo-
tide probe (5V-CCGGGTGACTGCCATGGAACACTT-3V;
Perkin Elmer Applied Biosystems, Foster City, CA)
corresponds to NT 463–486 in mouse GDF-9 mRNA
and was covalently linked to the fluorescent dye FAM
at the 5V-end and the quencher dye TAMRA at the 3V-end.
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ward primer (5V-GTTGCAGCCAGCTCCCTTAG-3V) cor-
responding to NT 562–581 and 3V reverse primer (5V-
GTCCATTGTAGG-CCCGAGTCT-3V) complementary to
NT 627–647 in mouse c-kit ligand mRNA (GenBank
accession number NM_013598). The internal fluorescent
oligodeoxynucleotide probe (5V-AGGAAAGCCGCAAA-
GGCCCCTG-3V) corresponds to NT 604–625 in the KL
mRNA. All primers were selected with the assistance
of the program Primers Express (Perkin Elmer Applied
Biosystems). The primers and PCR conditions used to
quantify FSHR mRNA by RealTime PCR were those
recently described (Romero et al., 2002). The 18S
ribosomal RNA was used as a normalizing unit for each
reaction using a set of primer’s purchased as a kit
(TaqMan Ribosomal RNA Control Reagents Kit, Perkin
Elmer Applied Biosystems).Fig. 2. Detection of full-length and truncated TrkB receptor isoforms in the devel
Western blot analysis. Ovaries from 7-day-old trkB +/+ and trkB / mice w
TrkB immunoreactive cells are seen in green, and cell nuclei stained with the D
full-length TrkB receptors detected with polyclonal antibodies against the intrac
primordial follicles (single layer of flattened pregranulosa cells, short arrow)
cuboidal granulosa cells, long arrow). (B) Persistence of low levels of full-length
follicles (one single cuboidal layer of cells, large single arrowhead) and seconda
of the receptors in granulosa cells of the same follicles (small arrowheads
immunoreactivity in granulosa cells of a growing primary follicle (small arrow
mouse. (E–G) Abundance of truncated TrkB-T1 receptors in oocytes of the 7-
intracellular domain of this receptor isoform. (E and F) T1 receptors are expres
abundant in oocytes of growing primary (type 3b) follicles and secondary follicle
absent in the ovary of a trkB / mice. (H) Western blot analysis of the TrkB
onto the lane. Note that in agreement with the immunohistochemical results, the
bars = 10 AM.Measurement of serum gonadotropins
LH and FSH were measured by radioimmunoassays
using reagents provided by the NIH National Pituitary
Agency. The binding in the LH assay was 30% and the
sensitivity is 0.7 ng/ml. The standard curve had a correlation
coefficient of r2 = 0.999. The FSH assay had a binding of
21%, a sensitivity of 0.4 ng/ml, and a correlation coefficient
of r2 = 0.995.
Data analysis
The differences in follicle numbers and gonadotropin
concentrations were analyzed using one-way ANOVA and
the appropriate post hoc test (Student’s t test to compare two
groups and Student–Newman–Keuls multiple test for indi-
vidual means to compare more than two groups).oping mouse ovary by immunohistofluorescence-confocal microscopy and
ere used. Three animals of each genotype were examined. In all panels,
NA-binding dye Hoechst are shown in blue. (A–D) Low abundance of
ellular domain of rat TrkB. (A) Detection of the receptors in oocytes of
and small, nongrowing primary (type 3a) follicles (one single layer of
TrkB receptor immunoreactivity in oocytes of growing primary (type 3b)
ry follicles (two layers of cells, large double arrowheads) and appearance
). (C) Higher magnification image showing full-length TrkB receptor
heads). (D) Lack of TrkB immunoreactivity in the ovary of a trkB /
day-old mouse ovary detected with antibodies that recognize the unique
sed at low levels in oocytes of primordial follicles (short arrows) but are
s (large single and double arrowheads, respectively). (G) T1 receptors are
protein. A protein extract from 30 TrkB heterozygous ovaries was loaded
majority of the TrkB receptors present in the ovary are truncated. Scale
Fig. 3. Truncated TrkB-T1 receptors become abundantly expressed in oocytes and targeted to the oocyte’s cell membrane when primary follicles initiate
growth. (A) View of a wild-type 7-day-old mouse ovary showing that the membrane-specific protein CD9 (red color) is present in oocytes at all stages of
development, whereas TrkB-T1 (green color) becomes targeted to the oocyte’s cell membrane only in growing primary and secondary follicles (large single and
double arrowheads, respectively). TrkB-T1 abundance is also markedly increased in these follicles as compared with primordial follicles. (B and C) Oocytes of
primordial (short arrows) and small primary follicles (long arrow) contain low levels of TrkB-T1 receptors, which are not targeted to the cell membrane. (D and
E) TrkB-T1 immunoreactivity becomes abundant and targeted to the cell membrane in oocytes of growing primary (large single arrowhead) and secondary
follicles (large double arrowhead). (F–H) images demonstrating that TrkB-T1 receptors (F, green color) in a growing primary follicle are localized to the same
peripheral region of the oocyte that contains an abundance of CD9 (G, red color). The overlap of both immunoreactivities (yellow color) is illustrated by the
merged images depicted in H. Scale bars in A = 20 Am; scale bars in B–H = 10 Am.
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Generation of mice lacking both full-length and truncated
TrkB receptors
Since the initially reported trkB knockout mice still
express truncated TrkB receptors (Klein et al., 1993), the
truncated TrkB protein may result in dominant negative
effects due to the capacity of its extracellular domain to
interfere with NT-3 signaling (Conover et al., 1995). In
addition, these mutant mice cannot be used to study
potential functions of the truncated TrkB receptor. To
define the function of TrkB in the ovary, we used mice
carrying a new trkB mutant allele, trkBneo. To generate this
mutant, the first coding exon of the trkB gene was replaced
with the neo selection gene (Fig. 1A). This replacement
blocks transcription of the trkB gene and prevents the
membrane expression of any TrkB protein that may still
be present by removing the signal peptide encoded in the
first exon. The trkBneo allele was identified by SouthernFig. 4. Detection of the TrkB ligands, NT-4 and BDNF, in the developing mouse
light microscopy. Ovaries from 7-day-old trkB +/+ and trkB / mice were
immunoreactive cells are seen in green and cell nuclei stained with the DNA-bind
cells are brown and cell nuclei stained with Gill’s hematoxylin are purple. (A–D
follicles. (A) Oocytes of primordial (short arrows) and small, nongrowing primar
material. (B) The oocytes of some growing primary (large single arrowhead) and
some follicles (small arrowheads) contain BDNF. (C) Higher magnification image
follicle (small arrowheads). (D) Section from a BDNF / mouse ovary showing l
oocytes and granulosa cells of newly formed follicles. (E) NT-4 is detected in oo
follicles (large single arrowheads), and (G) secondary follicles (large double arrowh
Section incubated with NT-4 antibodies preadsorbed with the NT-4 peptide used
20 Am.blot analysis with both 5V and 3V probes (probes A and B)
(Fig. 1B). As revealed by Northern hybridization, mice
homozygous for the trkBneo allele expressed a small
amount of an aberrantly sized mRNA (Fig. 1C, asterisk).
Despite the presence of this mRNA, Western blots with a
polyclonal antiserum against the TrkB extracellular domain
unambiguously demonstrated that no TrkB receptors were
expressed in the trkBneo mutant mice (Fig. 1D). Therefore,
the trkBneo allele is a null locus in which both the full-
length and truncated TrkB receptors are eliminated. This
trkB mutant has been previously used to examine the role
of TrkB in the development of the retina (Rohrer et al.,
1999).
Most TrkB receptors in the infantile mouse ovary are
truncated and expressed in oocytes
To identify the cells expressing TrkB receptors in the
developing mouse ovary, we used specific antibodies in
immunohistochemical reactions visualized by confocalovary by immunohistofluorescence-confocal microscopy and conventional
used. Three animals of each genotype were examined. In panels A–D,
ing dye Hoechst are shown in blue. In panels E–H, NT-4 immunoreactive
) BDNF is present in both oocytes and granulosa cells of newly formed
y follicles (long arrow) contain moderate levels of BDNF immunoreactive
secondary follicles (large double arrowheads), as well as granulosa cells of
showing BDNF immunoreactivity in granulosa cells of a growing primary
ack of BDNF immunoreactivity. (E–H) Like BDNF, NT-4 is also present in
cytes of primordial follicles (short arrows); (F) in growing type 3b primary
eads), NT-4 immunoreactivity is predominantly seen in granulosa cells. (H)
to raise the antibodies. Scale bars in A–D = 10 Am. Scale bars in E–H =
A. Paredes et al. / Developmental Biology 267 (2004) 430–449438microscopy (Fig. 2). We examined ovaries from 7-day-old
mice because at this time follicular assembly is completed
and gonadotropin-independent follicular growth is wellunder way. Although the use of frozen sections from
ovaries fixed in a paraformaldehyde-based fixative
resulted in oocyte shrinking as compared with ovaries
A. Paredes et al. / Developmental Biology 267 (2004) 430–449 439fixed in a denaturing fixative and embedded in paraffin
(see for instance Fig. 4), the basic morphological char-
acteristics of the follicles remained distinctly evident.
Primordial follicles are the initial result of follicular
assembly; they contain an oocyte surrounded by a single
layer of flattened pregranulosa cells (types 1 and 2;
Peters, 1969) (Fig. 2, short arrows). Primordial follicles
become primary follicles (type 3a) (Peters, 1969) by a
process that results in the differentiation of the flattened
granulosa cells into a cuboidal morphology (Fig. 2A, long
arrow) (Hirshfield, 1991; Peters, 1969). Granulosa cell
proliferation and oocyte growth begin at this point
resulting in the formation of larger (type 3b) primary
follicles first and secondary follicles with two (type 4) or
more layers of granulosa cells (type 5 and larger)
subsequently (Fig. 2, large single and double arrowheads,
respectively).
Antibodies that recognize the full-length TrkB receptor
demonstrated low levels of immunoreactive material in
oocytes of primordial follicles (Fig. 2A, short arrow),
nongrowing primary follicles (Fig. 2A, long arrow), and
growing primary and secondary follicles (Fig. 2B, large
single and double arrowheads, respectively). In all cases,
only a fraction of the receptors appeared to be associated
with the cell membrane. Full-length TrkB receptors were
also detected, albeit at low levels in granulosa cells of
growing primary and secondary follicles (Figs. 2B and C,
small arrowheads). The image in panel C is an enlarged
view of a portion of panel B highlighting the presence of
low levels of full-length TrkB receptor immunoreactivity in
granulosa cells (small arrowheads) of a primary follicle. The
ovaries from trkB / mice, used as controls, showed no
detectable TrkB immunoreactivity demonstrating the spec-
ificity of the staining (Fig. 2D).
Besides the full-length TrkB receptor, alternative
splicing of the trkB pre-mRNAs also generates two
truncated protein isoforms (Klein et al., 1990; Middle-
mas et al., 1991). These isoforms, termed T1 and T2
(Middlemas et al., 1991), lack the tyrosine kinase
domain and have unique short intracellular domains.
We used an antibody that specifically recognizes T1,
the predominant truncated receptor expressed in various
tissues (Shelton et al., 1995), to determine if this form is
expressed in the mouse ovary. In contrast to the low
levels of full-length TrkB receptor detected in growing
follicles, the T1 receptor was abundantly expressed inFig. 5. Infantile ovarian follicular development is delayed in a gonadotropin horm
NT-4 and BDNF genes. (A and B) Serum FSH levels (A), but not LH (B), are mild
show a defect in follicular development. (C) The number of primordial follicles
Selective reduction of secondary but not primary follicles in the ovaries of trkB 
ovaries of 10-day-old mice lacking both NT-4 and BDNF, as compared to the o
Microphotographs of ovaries from 7-day-old trkB +/+, trkB +/, and trkB / m
loss of TrkB-mediated signaling. The genotype of each animal was determined by
both trkB +/+ and trkB +/ mice show numerous secondary follicles (examples de
that show a normal number of primary follicles and a reduced population of second
represent SEM. Numbers above bars indicate number of animals per group.oocytes of both growing primary and secondary follicles
(Figs. 2E and F, large single and double arrowheads,
respectively). The oocytes from primordial follicles
showed a much lower level of T1 expression (Figs.
2E and F, short arrows). Likewise, no significant T1
expression was seen in granulosa cells at any stage of
follicular development (Figs. 2E and F). The specificity
of the TrkB T1 immunoreactivity was demonstrated by
its absence in the ovaries from trkB / mice (Fig.
2G). To biochemically define the presence of truncated
TrKB receptors in the developing mouse ovary and
verify the relative levels of expression of full-length
and truncated receptors suggested by the immunohisto-
chemical studies, we prepared protein extracts from
ovaries dissected from 7-day-old mice and performed
Western blots using antibodies specific to the TrkB
extracellular domain. Consistent with the immunohisto-
chemical observations, the immunoblot analysis showed
that most TrkB receptors in the infantile mouse ovary
are truncated (Fig. 2H).
We next performed double immunohistofluorescence
staining to determine if TrkB-T1 receptors are in fact
localized to the oocyte’s cell membrane. Using single
confocal optical sections (approximately 0.5 Am in thick-
ness), we found that CD9—a cell transmembrane protein
selectively expressed in mammalian oocytes (Zhu et al.,
2002)—is present in oocytes at all stages of development
(Fig. 3), including those in primordial follicles (short
arrows, red color), growing primary (large single arrow-
heads), and secondary follicles (large double arrowheads).
The yellow color in these two cases reflects the colocaliza-
tion of CD-9 (red) with TrkB-T1 immunoreactivity (green,
see below). In contrast to CD9, TrkB-T1 receptors are most
abundantly expressed in oocytes of primary and secondary
follicles (Fig. 3A). Surprisingly, TrkB-T1 receptors were
not localized to the cell membrane of oocytes in either
primordial (Figs. 3A and B, examples denoted by short
arrows) or small nongrowing primary follicles (Fig. 3C).
Receptors targeted to the cell membrane were first observed
in oocytes of growing primary follicles (Fig. 3D) and
became a distinct feature of secondary follicles (Fig. 3E).
Figs. 3F–H illustrate this localization by separately show-
ing the cellular distribution of TrkB-T1 immunoreactive
material (panel F) and CD9 (panel G) in an oocyte of a
growing primary follicle. The merged images are shown in
panel H.one-independent manner in TrkB-deficient mice and mice lacking both the
ly reduced in both trkB +/ and trkB / mice, but only trkB / animals
is similar in the ovaries of 7-day-old trkB / and wild-type mice. (D)
/ mice. (E) Similar reduction in the number of secondary follicles in the
varies of wild-type controls and ovaries from mice lacking NT-4. (F–H)
ice illustrating the deficiency in early follicular growth associated with the
PCR analysis of tail DNA before sectioning the ovaries. The ovaries from
noted by double arrowheads), in contrast to the ovaries from trkB / mice
ary follicles. Scale bars = 50 Am. In A–E, bars are means and vertical lines
A. Paredes et al. / Developmental Biology 267 (2004) 430–449440The infantile mouse ovary expresses both NT-4 and BDNF,
the two known TrkB ligands
We next determined the expression sites of BDNF and
NT-4 in the ovary. Figs. 4A and B show that BDNF is
expressed at low levels in the oocytes of primordial (short
arrows), nongrowing, and growing primary follicles (long
arrows and large single arrowheads, respectively) and
secondary (large double arrowheads) follicles. More no-
ticeable, however, is the appearance of BDNF in gran-
ulosa cells of growing primary and secondary follicles
(Figs. 4B and C, large single and double arrowheads).
Fig. 4C shows a higher magnification view of a growing
primary follicle highlighting the presence of BDNF in
granulosa cells (small arrowheads). No BDNF immuno-
reactivity was detected in the ovary from a BDNF /
mouse (Fig. 4D).
Because we could not reliably localize NT-4 by
immunohistofluorescence in Zamboni-fixed ovaries, we
used a denaturing fixative and thin paraffin-embedded
section for this purpose. As shown in Figs. 4E–H, NT-
4 shows a developmental pattern of expression similar to
that of BDNF. Initially, NT-4 immunoreactivity is present
in the oocytes of primordial follicles (Fig. 4E, short
arrows) but switches to granulosa cells when the follicles
reach the primary and secondary stages (Figs. 4F and G,
large single and double arrowheads, respectively). Pread-
sorption of the primary antibody with its antigenic peptide
(NT-4) completely eliminated the immunoreactive reac-
tions in both cases (Fig. 4H). Thus, the developing mouse
ovary contains the complete ligand receptor system re-
quired for neurotrophin-dependent, TrkB-mediated cellular
signaling.
Lack of TrkB receptors delays ovarian follicular growth but
it does not affect the size of the primordial follicle
population present at the end of the first week of postnatal
life
The original TrkB KO mice lack the full-length TrkB
receptor but still express truncated TrkB receptor isoforms
(Klein et al., 1993). They show developmental defects of
the central and peripheral nervous system and die at birth
(Klein et al., 1993). Although the mutant mice described in
the present report survive longer, they show similar neu-
rological defects and are smaller than their littermates
(Rohrer et al., 1999). Thus, potential defects in early
postnatal ovarian development may be caused by extra-
ovarian deficiencies in either the neural or endocrine
control of the ovary. A neural defect can be ruled out
because animals lacking the ovarian innervation do not
show a deficit in preantral follicular development (Lara et
al., 1990). To determine if the hypothalamic–pituitary unit
is affected in trkB KO animals, we measured serum LH
and FSH levels in 7-day-old trkB +/+, trkB +/, and trkB
/ mice. The results showed that while LH levels werenormal in the mutant mice, serum FSH levels were
reduced by about 25% in both trkB +/ and trkB /
mice (Figs. 5A and B). Next, we performed a morpho-
metric analysis of the ovary to compare the degree of
follicular growth achieved in wild-type and TrkB-deficient
mice at this postnatal age. To determine if the reduction in
serum FSH observed in trkB / and +/ mice affects
follicular growth independently of the presence or absence
of TrkB receptors, we also analyzed the ovaries of trkB
+/ mice and compared them to the glands of trkB +/+
animals.
We observed that the number of primordial follicles per
ovary was similar in trkB +/+ and trkB / ovaries (Fig.
5C), indicating that TrkB receptor signaling is not required
for follicular assembly. The number of primary follicles per
ovary was also similar in trkB / ovaries as compared to
both wild-type and trkB +/ mice, but the number of
secondary (two-layer stage) follicles was strikingly reduced
in the trkB / animals (Fig. 5D, microphotographs in
Figs. 5F–H). To determine if the deficiency in secondary
follicles is caused by the loss of NT-4 and/or BDNF-
initiated signaling, we quantified the number of secondary
follicles in mice lacking either NT-4 (Conover et al., 1995)
or both genes (Conover et al., 1995). The results showed
that the loss of NT-4 in mice with an intact BDNF or TrkB
signaling complex does not alter the number of secondary
follicles per ovary (Fig. 5E). Instead, the concomitant loss of
the NT-4 and BDNF genes results in a deficiency in
secondary follicle formation similar to that detected in trkB
/ mice (Fig. 5E). Thus, in the absence of NT-4, there is a
compensatory activation of ovarian TrkB receptors by
BDNF, the remaining ligand.
Absence of TrkB receptors during the first week of postnatal
life results in decreased proliferation of granulosa cells
The growth of primary into secondary follicles requires
proliferation of granulosa cells (Hirshfield, 1991; Oktay et
al., 1995). To determine if the deficiency in follicular
growth seen in trkB / mice is related to a reduction
in granulosa cell proliferation, we estimated the prolifera-
tive activity of these cells by two independent methods,
the immunohistochemical detection of the proliferation
marker PCNA and the incorporation of BrdU into cell
nuclei after exposing the ovaries from trkB +/+ and trkB
/ mice to the nucleoside for 24 h in organ culture. Fig.
6 shows that both the total number of proliferating
granulosa cells per ovary, estimated by PCNA immuno-
histochemistry (Figs. 6A–C), and the proliferation ratio
estimated by the ratio of BrdU positive/BrdU negative
cells (Figs. 6D–F) were significantly reduced in trkB /
ovaries. The microphotographs depicted in panels B and C
(PCNA staining) and E and F (BrdU staining) illustrate
these changes in addition to demonstrating that within
individual follicles, there are fewer proliferating granulosa
cells in trkB / than wild-type ovaries (examples
Fig. 6. Granulosa cell proliferation at the end of the first postnatal week of life is decreased in TrkB-deficient mice, without a concomitant increase in apoptotic
cell death. (A–F) Decreased number of cell nuclei positive for the proliferation markers PCNA (A–C) and BrdU (D–F) in granulosa cells of trkB / ovaries
analyzed at the end of the first postnatal week of life (day 7). (A) Number of PCNA-positive granulosa cells per ovary. (D) Ratio of BrdU positive/total
granulosa cells per ovary. Bars are means and numbers on top of bars are number of animals per group. Vertical lines are SEM. (B and C) Microphotographs of
ovarian sections from trkB +/+ and trkB / mice stained with antibodies to the proliferation marker PCNA and counterstained with Gill’s hematoxylin. (E and
F) Microphotographs of ovarian sections from trkB +/+ and trkB / mice stained with antibodies to BrdU and counterstained with nuclear fast red. Arrows
denote follicles showing a predominance of nonproliferating granulosa cells. Scale bars = 50 Am. (G and H) The stunted development of ovarian follicles
associated with the loss of TrkB receptors is not accompanied by increased apoptotic cell death, as determined by a TUNEL fluorescence assay. (I) Follicles
from a prepubertal 34-day-old ovary showing numerous apoptotic cell nuclei in the granulosa cell compartment of atretic antral follicles. The extensive
apoptosis seen in these cells (green nuclei) is in contrast with the almost complete absence of apoptotic nuclei in the follicles of infantile ovaries (7-day-old)
mice having either a normal complement of trkB receptors (+/+, G) or lacking all trkB receptor forms (/, H). The images depicted represent observations
made in ovaries from three 7-day-old mice per genotype and two wild-type late juvenile mice. Scale bars = 25 Am.
A. Paredes et al. / Developmental Biology 267 (2004) 430–449 441denoted by arrows). The greater difference in number of
proliferating cells determined by PCNA immunostaining
(panel A) as compared with the difference in proliferation
ratio assessed by BrdU incorporation (panel D) may be
related to the detection of PCNA in mitogenically inactive
cells (Jaskulski et al., 1998). Because up-regulation of
PCNA expression in quiescent cells can be elicited by
growth factors, such an increase would be more likely tooccur in granulosa cells with an intact growth factor
system than in trkB / ovaries.
Absence of TrkB receptors during the first week of life does
not increase ovarian cell apoptosis
Disruption of the trkB gene results in apoptotic cell death
in the nervous system (Klein et al., 1993). To determine if
A. Paredes et al. / Developmental Biology 267 (2004) 430–449442the absence of TrkB receptors during the first week of
postnatal life resulted in cell death of either granulosa cells
or oocytes, we performed TUNEL assays on ovarian sec-
tions from 7-day-old wild-type and trkB / mice. Theresults showed that apoptotic cell death in these young
ovaries was minimal in both wild-type and KO ovaries
(Figs. 6G and H) in contrast to the abundance of apoptotic
granulosa cells in atretic antral follicles of older prepubertal
A. Paredes et al. / Developmental Biology 267 (2004) 430–449 443animals (Fig. 6I). Thus, the relative inability of trkB-defi-
cient ovaries to sustain the growth of primary follicles does
not seem to be brought about by an increased cell death of
either oocytes or granulosa cells. In this sense, the ovaries
from trkB / mice behave like the ovaries of normal
animals in which granulosa cells of preantral follicles
undergo almost no apoptosis (Hirshfield, 1991).
Absence of TrkB receptors during the first week of postnatal
life does not reduce the expression of growth factors
required for early follicular growth
Previous studies have shown that the oocyte-derived
growth factor GDF-9 and the granulosa cell product KL
do not influence follicular formation but are required for
the initiation of follicle growth (Dong et al., 1996; Huang
et al., 1993). Both the genetic ablation of GDF-9 (Dong
et al., 1996) and natural mutations in the steel panda gene
encoding KL (Huang et al., 1993; Kuroda et al., 1988)
result in arrest of follicle development at the primary 3b
stage, that is, at the same stage where an arrest of
follicular development becomes apparent in trkB /
mice. In the absence of GDF-9, granulosa cells prolifer-
ation is reduced (McGrath et al., 1995), just as it happens
in trkB / mice. While KL acts via the receptor
tyrosine kinase c-kit, which is predominantly expressed
in oocytes (Manova et al., 1990), a recent report (Vitt et
al., 2002) showed that GDF-9 is recognized by bone
morphogenetic protein receptor II (BMPRII), a receptor
expressed in granulosa cells (Shimasaki et al., 1999). To
determine if the absence of TrkB signaling might result in
reduced expression of these proteins, the encoding
mRNAs were quantified by either RealTime PCR (the
ligands GDF-9 and KL) or Relative Quantitative PCR
(the receptors BMPRII and c-kit). As shown in Fig. 7, the
abundance of the two mRNAs expressed in oocytes, the
ligand GDF-9 (panels A and C) and the receptor c-kit
(panels F and H), was essentially the same in trkB /
and wild-type ovaries, indicating that the supportive effectFig. 7. The ovarian content of the mRNAs encoding GDF-9 and its presumed rece
(A and B) Representative RealTime PCR amplification profiles of GDF-9 mRNA (
of wild-type littermates. The insets depict the standard curves use to estimate the a
using serial dilutions of reverse transcription reactions derived from one Ag of to
RNA). The values obtained were normalized using the values of 18S ribosomal RN
for ribosomal RNA were those provided in the TaqMan ribosomal RNA Contro
reactions were carried out as described (Romero et al., 2002) using an ABI Prism
total volume of 10 Al, containing 2 Al of reverse transcription reaction, 5 Al of Taq
Al primer mix (250 nM of each gene-specific and ribosomal fluorescent probes
unlabeled ribosomal primer). (C and D) Ovarian content of GDF-9 (C) and KL (D
mice. (E and F) Representative ethidium bromide-stained gels showing BMPRII (
Relative Quantitative PCR conditions described in Materials and methods. (G an
Relative Quantitative PCR. Values are shown as ratios between the gene-specific s
gene of interest. Bars are mean F SEM and numbers on top of bars are number
granulosa cells, the values obtained in trkB / mice were corrected to take in
animals.of NTs acting via TrkB receptors on early follicular
growth does not require the intermediacy of these oo-
cyte-derived molecules. A similar analysis was performed
for the mRNAs encoding the granulosa cell located GDF-
9 receptor BMPRII and the granulosa cell-secreted c-kit
ligand KL. Because the total number of granulosa cells
per ovary was reduced by 23% in trkB / mice, the
BMPRII and KL mRNA values detected in trkB /
ovaries were corrected by this factor. The results showed
that the content of both mRNAs remained essentially
unchanged in the KO ovaries, with a small increase being
statistically significant (P < 0.01) for BMPRII (Figs. 7E
and G, B and D). Thus, neither of these oocyte-granulosa
cell communication complexes seems to be a downstream
component underlying the supportive effect of TrkB
receptor activation on follicular growth.
Absence of trkB receptors results in decreased expression of
FSH receptors
As ovarian follicles grow beyond the primary stage,
granulosa cells acquire FSH receptors (Oktay et al., 1997)
and become responsive to the gonadotropin (Sokka and
Huhtaniemi, 1990). Experimental induction of FSHR
synthesis at this stage of development allows secondary
follicles to acquire additional layers of granulosa cells in
response to FSH (Romero et al., 2002). The finding that
follicular growth in mice lacking the FSHR gene pro-
gresses only to the secondary two-layer stage (Kumar et
al., 1997) indicates that this is indeed the developmental
phase during which the growth of ovarian follicles be-
come gonadotropin dependent. RealTime PCR measure-
ment of FSHR mRNA demonstrated that in keeping with
the deficiency in secondary follicles observed at the end
of the first week of postnatal life in TrkB-deficient mice,
the content of FSHR mRNA (corrected as in the case of
BMPRII and KL) is strikingly reduced in the ovaries of
these animals as compared with either trkB +/+ or trkB +/
 mice (Fig. 8). The FSHR mRNA content in trkB +/ptor, BMPRII, and KL and its c-kit receptor is not altered in trkB / mice.
A) and KL mRNA (B) from the ovary of trkB / mice compared with that
mount of each mRNA present in the two groups. The curves were generated
tal RNA from 7-day-old mouse ovaries (equivalent to 101–108 Ag total
A amplified with each reaction as an internal control. The primers and probe
l Reagents Vic probe Kit (Perkin Elmer Applied Biosystems). The PCR
7700 sequence Detection System (Perkin Elmer Applied Biosystems), in a
Man Universal PCR Master Mix (Perkin Elmer Applied Biosystems), and 3
and 300 nM of each gene-specific unlabeled primer plus 80 nM of each
) mRNA detected by RealTime PCR in wild-type and trkB / 7-day-old
E) and c-kit (F) PCR products amplified from total ovarian RNA using the
d H) Relative content of BMPRII (G) and c-kit (H) mRNAs estimated by
ignal and the signal provided by 18S ribosomal RNA coamplified with each
of mice per group. Because the KL and BMPRII mRNAs are expressed in
to consideration the reduction in granulosa cell number observed in these
Fig. 8. Reduced FSHR mRNA content in the ovaries of 7-day-old trkB /
mice as compared with wild-type and trkB +/ animals. (A) Linear
regression analysis of the standard curve used to calculate the mRNAvalues
shown in B. The curve depicted resulted from the amplification of different
amounts (0.1–100,000 fg/tube) of in vitro transcribed sense FSHR RNA
standard. (B) Mean FSHR mRNA content in the ovaries from trkB +/+, trkB
+/, and trkB / mice. Vertical lines are SEM, and numbers above bars
are number of mice per group.
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follows that in the absence of TrkB signaling, follicles fail
to reach the stage in which they will continue to grow
under pituitary gonadotropin control.
Sustained absence of TrkB receptors results in oocyte death,
interruption of follicle growth, and widespread degradation
of follicular organization
Because TrkB-deficient mice are in poor health, it is
difficult to study the development of the ovary after the
first week of postnatal life. To overcome this limitation, we
transplanted the ovaries of 4- to 5-day-old trkB +/+, trkB
+/, and trkB / mice under the kidney capsule of adult
female C57BL/6J mice and evaluated the morphological
aspect of the ovaries 2 weeks after transplantation. The
ovaries (n = 4) from trkB +/+ mice contained numerous
follicles in different stages of development (Fig. 9A),including follicles that had reached the antral stage (exam-
ples denoted by arrows). Likewise, oocyte development
appeared normal as evidenced by the presence of healthy
oocytes at different stages of development (Fig. 9A). The
morphological aspect of trkB +/ ovaries (n = 6) was
indistinguishable from that of wild-type ovaries. They also
had antral follicles in various stages of growth and con-
taining healthy oocytes (Fig. 9B, examples denoted by
arrows). One such follicle is shown at higher magnification
in panel D. In striking contrast, the ovaries of trkB /
mice (n = 6) were essentially depleted of oocytes (Fig.
9C). The few oocytes still present appeared to be in
advanced stages of degeneration (examples denoted by
arrows in Fig. 9C and in the higher magnification image
shown in Fig. 9E). Although trkB / exhibited remnants
of follicles that had progressed beyond the primary stage
(example denoted by double arrows in Fig. 9E), structural
dissolution was evident in several follicles containing a
dying oocyte. In these follicles, the integrity of the basal
lamina appeared compromised so that the granulosa cells
were no longer contained within individual follicles
(arrowheads in Fig. 9E). In the absence of oocytes, the
identity of individual follicles disappeared (Fig. 9F). Sur-
prisingly, no overt morphological signs of granulosa cell
death were detected in follicles that had loss or were in the
process of losing, their oocyte (Figs. 9E and F).Discussion
The present study provides evidence for the involvement
of TrkB receptors in the development of an endocrine organ.
Using trkB-null mice that lack all forms of the receptor, we
show that during the early stages of the deficiency (assessed
in ovaries in situ at the end of the first postnatal week of
life), follicular growth is impaired at the stage during which
primary follicles (type 3b) begin to grow. Transplantation of
trkB / ovaries under the kidney capsule of adult mice
revealed that the sustained absence of TrkB receptors results
in oocyte death, absence of antral follicle formation, and
dissolution of follicular boundaries.
Morphometric analysis of 7-day-old trkB / ovaries
demonstrated that the deficiency selectively affects the
development of secondary follicles, which requires mito-
genic activation of granulosa cells (Lintern-Moore and
Moore, 1979; Oktay et al., 1995), but not the presence of
gonadotropin hormones (Dierich et al., 1998; Kumar et al.,
1997; Zhang et al., 2001). Granulosa cells of trkB /
ovaries exhibit a marked decrease in proliferative activity,
without obvious apoptosis, indicating that the growth defect
is primarily related to a reduction in cell proliferation and
not caused by an increase in programmed cell death.
Because mice carrying a deletion of both the NT-4 and
BDNF genes show a similar deficiency of follicular growth,
it is clear that the defect is caused by the loss of NT-4 or
BDNF signaling through TrkB receptors. In addition, the
Fig. 9. Sustained absence of TrkB receptors results in oocyte death, interruption of follicle growth and loss of follicular organization. To examine the
consequences of the absence of TrkB receptors on follicular growth beyond the first week of life the ovaries of 4- to 5-day-old trkB +/+, trkB +/, and trkB/,
mice were transplanted under the kidney capsule of adult female C57BL/6J mice and their morphological aspect was evaluated 2 weeks after transplantation. (A)
Ovary from a trkB +/+ showing numerous follicles in different stages of development, including follicles that had reached the antral stage (arrows). (B) Ovary
from a trkB +/ mouse exhibiting a degree of follicular development indistinguishable from that of wild-type ovaries. (C) Ovary from a trkB / mouse
showing marked depletion of oocytes and loss of follicular boundaries. The few oocytes still present appear to be in advanced stage of degeneration (arrows). (D)
Higher magnification image illustrating the presence of normal antral follicles containing healthy oocytes in trkB +/ ovaries. (E) High magnification image of a
trkB/ ovary demonstrating the presence of dying oocytes (arrows) in follicles still intact (double arrow) and follicles undergoing dissolution as evidenced by
the loss of basal lamina continuity (arrowheads). (F) Widespread loss of follicular structure in the absence of oocytes. Even in the absence of oocytes or follicular
structure, the granulosa cells appear normal. Scale bars in A–C = 200 Am; in D and E = 20 Am; in F = 50 Am.
A. Paredes et al. / Developmental Biology 267 (2004) 430–449 445normal number of secondary follicles detected in mice
lacking only the NT-4 gene suggests that in the absence of
this ligand, BDNF assumes a compensatory role.
Although the number of secondary follicles in TrkB-
deficient mice was reduced, this deficiency was not accom-
panied by significant changes in the number of primordial or
primary follicles. Because a selective reduction in secondary
follicles would be expected to be accompanied by accumu-
lation of primary follicles, the lack of such an increase
suggests that the transition of primordial to primary follicle
may be also compromised in trkB KOs. However, the
subtlety of this change makes it unlikely that a reduction
in the formation of primary follicles is the primary mech-
anism by which the lack of TrkB receptors impairs the
formation of secondary follicles.
The ovarian phenotype observed at the end of the first
postnatal week of life in trkB KO mice is similar to that
of mice lacking GDF-9, an oocyte-derived growth factor
member of the TGF-h superfamily (Elvin et al., 2000).
Like in trkB KOs, the growth of primary one-layer (type
3b) into secondary two-layer (type 4) follicles is impaired
in GDF-9-deficient mice (Dong et al., 1996; Elvin et al.,
1999b). Also like in TrkB-deficient mice, GDF-9-null
mutants show a defect in granulosa cell proliferation,
but no increase in apoptotic cell death (Elvin et al.,1999b). Furthermore, the oocyte expression of both trun-
cated TrkB receptors (this paper) and GDF-9 (Elvin et al.,
1999a) becomes first evident in primary type 3a follicles,
increasing markedly thereafter. It does not appear, how-
ever, that the two systems are functionally or hierarchi-
cally related because GDF-9 mRNA expression was
normal in trkB KOs as was the expression of BMPRII,
a serine or threonine kinase receptor recently shown to be
a receptor for GDF-9 (Vitt et al., 2002). In fact, when the
BMPRII mRNA values were corrected to reflect the
smaller number of granulosa cells present in trkB /
ovaries, a significant increase in the mRNA content
became apparent.
A fundamental difference between the ovaries of trkB
/ mice and those of mice lacking GDF-9 was revealed
by ovarian transplantation experiments. We used this
approach to overcome the limitation imposed by the poor
health of trkB / mice, which makes it difficult to assess
the consequences of trkB gene deletion on ovarian devel-
opment beyond the first week of postnatal life. The
transplantation of 4- to 5-day-old wild-type ovaries into
adult, ovariectomized wild-type mice demonstrated that, as
shown by others ((Liu et al., 2002) and references therein),
follicular development progresses unabated in the trans-
planted ovaries. We also observed that follicular growth in
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that of wild-type animals. In marked contrast, the ovaries
from trkB / mice exhibited a dramatic depletion of the
oocyte population and widespread arrest of follicle growth.
The few remaining oocytes showed signs of advanced
degeneration in the presence of apparently healthy gran-
ulosa cells. These changes are not seen in GDF-9-deficient
mice, in which oocytes grow more rapidly than in wild-
type animals and remain healthy despite the arrested
follicular growth (Carabatsos et al., 1998).
Because in transplanted trkB-null ovaries oocyte loss is
not accompanied by similar alterations in granulosa cell
viability, it appears warranted to conclude that oocytes
represent the primary target of ligand-dependent TrkB
receptor activation. These results and those obtained with
in situ 1-week-old ovaries suggest that once oocytes begin
to acquire functional TrkB receptors during the transition
from primary to secondary follicles, they become increas-
ingly dependent on TrkB-mediated signaling for survival
and development. Initially, the oocytes might not be able to
sustain cell–cell communication pathways necessary for
granulosa cell proliferation (Vanderhyden et al., 1992),
and the growth of primary follicles is delayed. Later on,
oocyte survival is compromised and this ultimately leads to
arrest of follicular growth. Follicular boundaries are then
lost resulting in widespread dissolution of follicular organi-
zation. Noteworthy, the aforementioned changes occur in
transplanted trkB / ovaries in the face of strong gonad-
otropin stimulation. This postulated sequence of events is in
keeping with recent findings demonstrating that oocytes
promote the differentiation and growth of granulosa cells
and determine the rate of follicular development (Eppig et
al., 2002). Because the elimination of oocytes before the
time of folliculogenesis by either pharmacological (Hirsh-
field, 1991) or genetic (Soyal et al., 2000) means results in
failure of follicular formation, it appears clear that oocytes
are essential for folliculogenesis, subsequent follicle growth
and follicle survival.
In 7-day-old trkB / ovaries, in situ follicular growth is
arrested at the primary 3b stage, but the follicles that could
still be discerned in transplanted trkB / appeared to have
progressed beyond the secondary stage. We interpret this
difference as due to both the transplantation procedure and
the hormonal environment to which the ovaries are sub-
jected when grafted into ovariectomized hosts. Within 12
h after transplantation, there is a massive apoptotic loss of
follicles, which is followed by recruitment of a new cohort
of primordial follicles for growth (Liu et al., 2002). Because
the host mice are ovariectomized, growth of these new
follicles proceeds under the influence of elevated FSH and
LH levels, which can hyperstimulate granulosa cell prolif-
eration despite an initially reduced complement of gonado-
tropin receptors resulting from the absence of TrkB
receptors (see below).
The distribution of NT-4 and BDNF in granulosa cells
and TrkB receptors in oocytes is similar to the KL or c-kitsignaling system, in which KL is produced by granulosa
cells (Joyce et al., 1999; Manova et al., 1993), and binds
to c-kit receptors expressed in the oocyte (Manova et al.,
1990). However, the ovaries of trkB-null mice show
normal levels of both KL and c-kit mRNA, indicating that
TrkB-mediated signaling does not require changes in
expression of the KL or c-kit signaling complex. It thus
appears that activation of ovarian TrkB receptors regulates
oocyte survival and follicle growth via unidentified path-
ways that function in parallel to those activated by KL in
the oocyte and GDF-9 in granulosa cells. These two
systems are also relatively independent from each other,
as animals lacking GDF-9 have elevated KL mRNA levels,
but a normal c-kit expression (Elvin et al., 1999b). FSHR
mRNA levels were strikingly reduced in in situ trkB /
ovaries, indicating that in the absence of TrkB receptors,
the attainment of a developmental stage in which the
follicles will acquire FSHRs, and thus become gonadotro-
pin dependent, is hampered. This selective deficiency in
FSHR gene expression in the face of a normal BMPRII
and KL mRNA levels (which like FSHRs are also
expressed in granulosa cells) indicates that the absence
of trkB signaling results in a growth defect affecting a
specific component of the ovary instead of a generalized
disruption of tissue development. That the reduction in
FSHR gene expression is not a consequence of the lower
serum FSH levels observed in trkB / mice is indicated
by the fact that a similar decrease in serum FSH occurs in
trkB +/ and yet follicular development was only impaired
in the former. The decrease in FSH levels might be related
to loss of a supportive TrkB effect on the release of
hypothalamic gonadotropin hormone-releasing hormone,
which controls pituitary FSH secretion.
The remarkable developmental patterns of cellular ex-
pression observed for both the TrkB receptors and their NT-
4 and BDNF ligands suggest that ovarian TrkB-dependent
signaling requires the interaction of granulosa cells and
oocytes. Although both NT-4 and BDNF are initially
detected in oocytes of primordial follicles, their site of
expression switches to granulosa cells at the outset of
follicular growth, indicating that somatic cells provide the
bulk of NT signals activating ovarian TrkB receptors at this
critical stage of follicular growth. Because low levels of full-
length TrkB receptors are detected in oocytes at all phases of
follicular development, but they can be detected in gran-
ulosa cells only in growing follicles, it might be concluded
that NT-4 and BDNF exert part of their facilitatory effects
on granulosa cell proliferation via paracrine and autocrine
loops that affect granulosa cells both directly and through
intermediacy of the oocyte.
Noteworthy, the majority of the TrkB receptors detected
in the infantile mouse ovary are truncated, exclusively
expressed in oocytes of growing follicles (type 3b onwards),
and strikingly more abundant than full-length receptors,
suggesting that they may play a significant role in the
control of oocyte functions. The unexpected finding that
A. Paredes et al. / Developmental Biology 267 (2004) 430–449 447truncated TrkB receptors become targeted to the oocyte’s
cell membrane only when primary follicles initiate growth
and the dramatic loss of oocytes observed in transplanted
trkB / supports this idea and suggests that truncated
TrkB receptors might also be important for oocyte survival.
The mechanisms underlying these effects are unknown.
Binding of NT-4 or BDNF to TrkB T1 receptors may
activate signaling pathways (Baxter et al., 1997; Kryl and
Barker, 2000) coupled to the production of proliferating
factors by the oocyte (Vanderhyden et al., 1992) and/or
required for oocyte survival. Alternatively, TrkB T1 recep-
tors in oocytes may bind NTs and present them to the full-
length receptors expressed in granulosa cells, which in turn
would provide signals (Carabatsos et al., 2000; Cecconi and
Rossi, 2001; Mehlmann et al., 2002) required for oocyte
survival and development. Further investigation is required
to clarify this issue.
We previously reported that the lack of NGF diminishes
both the differentiation of primordial into primary follicles
and growth of primary into secondary follicles and that this
defect is related to a deficiency in mesenchymal cell
proliferation (Dissen et al., 2001). By now showing that
NT-4 or BDNF facilitates the growth of primary follicles
and that the absence of TrkB receptors results first in
reduced granulosa cell proliferation and then oocyte death,
the present findings lend credence to the concept that
neurotrophins support the development of nonneural target
tissues, such as the ovary, by providing signals mediated by
their high-affinity receptors. Based on these observations,
we propose that neurotrophins are intraovarian factors that
contribute with KL and GDF-9 to the control of early
follicular development (Matzuk et al., 2002). While current
evidence suggest that KL and NGF promote the differenti-
ation of primordial follicles into primary follicles (Dissen et
al., 2001; Parrott and Skinner, 1999), the present data
indicate that NT-4 and BDNF may work in concert with
GDF-9, KL, and NGF in promoting the transition of primary
follicle into secondary stage. Our findings also suggest that
truncated TrkB receptors expressed in oocytes may play a
hitherto unsuspected role in mediating these effects. The
loss of oocytes seen in transplanted trkB / ovaries
suggests that a functional NT-4/BDNF-TrkB signaling com-
plex is essential for oocyte survival during preantral follicle
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